Literature DB >> 5917401

Immunosuppressive therapy in persistent glomerulonephritis.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5917401      PMCID: PMC1944107          DOI: 10.1136/bmj.2.5518.842

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  12 in total

1.  SELECTIVITY OF PROTEIN EXCRETION IN PATIENTS WITH THE NEPHROTIC SYNDROME.

Authors:  G R JOACHIM; J S CAMERON; M SCHWARTZ; E L BECKER
Journal:  J Clin Invest       Date:  1964-12       Impact factor: 14.808

2.  SELECTIVITY OF PROTEINURIA IN CHILDREN WITH THE NEPHROTIC SYNDROME.

Authors:  J S CAMERON; R H WHITE
Journal:  Lancet       Date:  1965-02-27       Impact factor: 79.321

Review 3.  IMMUNOSUPPRESSIVE AGENTS.

Authors:  M C BERENBAUM
Journal:  Br Med Bull       Date:  1965-05       Impact factor: 4.291

4.  Estimation of eight serum proteins by a gel diffusion precipitin technique.

Authors:  J F SOOTHILL
Journal:  J Lab Clin Med       Date:  1962-05

5.  The significance of serum complement levels for the diagnosis and prognosis of acute and subacute glomerulonephritis and lupus erythematosus disseminatus.

Authors:  K LANGE; E WASSERMAN; L B SLOBODY
Journal:  Ann Intern Med       Date:  1960-10       Impact factor: 25.391

6.  Prolonged intermittent steroid therapy for nephrosis in children and adults.

Authors:  K LANGE; E WASSERMAN; L B SLOBODY
Journal:  J Am Med Assoc       Date:  1958-09-27

7.  [Trial treatment of various glomerular nephropathies with nitrogen mustards].

Authors:  G LAGRUE; D FRITEL; P TCHERDAKOFF; J BARIETY; P SAMARCQ; P MILLIEZ
Journal:  Sem Hop Ther Paris       Date:  1962-05

8.  The simple assessment of selectivity in heavy proteinuria.

Authors:  J S Cameron; G Blandford
Journal:  Lancet       Date:  1966-07-30       Impact factor: 79.321

9.  The nephrotic syndrome of childhood: immunologic, clinical, and pathologic correlations.

Authors:  K N Drummond; A F Michael; R A Good; R L Vernier
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

10.  Mercaptopurine in the treatment of steroid-resistant nephrotic syndrome.

Authors:  M A Shearn
Journal:  N Engl J Med       Date:  1965-10-28       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.